Topic: Market Developments

Latest content

China brushes off EU request for more information on controversial SEP decisions

Response to a formal inquiry under the WTO’s TRIPS mechanism will frustrate those pushing for greater clarity on ASI decisions

08 September 2021

China surge in business method patents continues, while Japan and South Korea also see growth

Asia charts its own course as post-Alice slide continues in the United States and filing levels remain low in Europe

07 September 2021

Korean Intellectual Property Office inaugurates “tech police” unit to combat overseas IP leakage

A division devoted to IP investigations has been beefed up and charged with stopping the flow of trade secrets across borders

03 September 2021

Samsung Electronics signs up as a licensee to Sisvel’s cellular SEPs

Deal was forged with no litigation hovering in the background and is the latest in a line that the pair have concluded

02 September 2021

Qualcomm licensing chief is number one in IAM's Market Makers ranking of the world's IP business leaders

The Long Read: Alex Rogers heads the list of individuals who have shaped the global patent licensing and deals markets over the past year, with senior executives from both corporates and NPEs making up the rest of the top 10

01 September 2021

The world’s leading IP strategists named

The 2021 edition of the IAM Strategy 300 has been published and identifies gamechangers working inside corporations, aggregators, service providers, research institutions and universities, among others

31 August 2021

IP could become a $100 billion premium market, says Aon CEO

Greg Case has been bullish about the sector for a while and if he is right it could finally mean the birth of the asset class so many have been waiting for

30 August 2021

BlackBerry patent sale could be announced as soon as next month

Talks between the company and an unnamed group of US-based entities are progressing well with many key points, including pricing, now agreed in principle

27 August 2021

As solar patent war rolls on, Chinese panel leader says it has seen off biggest threats

JinKo Solar explains how a Sino-Korean patent battle has played out so far, revealing big differences in US and German results

27 August 2021

Pfizer’s $2.3 billion spend on CD47 inhibitors shows how oncology IP continues to drive pharma deal-making

The acquisition of the cutting-edge haematology candidates is just the latest development in the booming immuno-oncology market

26 August 2021

Get unlimited access to all IAM content